The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -67.45%.However, over the last six months, we can see a weaker performance of 4.19%. Over the last 30 days, the price of CRBU has leaped by -15.23%. And in the last five days, it has fallen by -12.44%.
Caribou Biosciences Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $8.33 on 02/28/24 and the lowest value was $1.50 on 07/09/24.
52-week price history of CRBU Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Caribou Biosciences Inc’s current trading price is -77.61% away from its 52-week high, while its distance from the 52-week low is 24.33%. The stock’s price range during this period has varied between$1.50 and $8.33. The Caribou Biosciences Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.66 million for the day, a figure considerably lower than their average daily volume of 1.29 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Caribou Biosciences Inc (CRBU) has experienced a quarterly decline of -8.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 168.88M and boasts a workforce of 158 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.0603, with a change in price of -0.3943. Similarly, Caribou Biosciences Inc recorded 1,186,558 in trading volume during the last 100 days, posting a change of -17.45%.
CRBU’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CRBU stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.09.
CRBU Stock Stochastic Average
Caribou Biosciences Inc’s raw stochastic average for the past 50 days is presently 7.78%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 6.58%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 9.91% and 13.95%, respectively.
